Navigation Links
SpectraCell Laboratories Expands Operations in New Facility
Date:10/27/2008

HOUSTON, Oct. 27 /PRNewswire/ -- SpectraCell Laboratories, Inc., announced that it has doubled the size of its facilities. Recently, SpectraCell occupied a 20,000 sq. ft. building that was custom designed for them in 2005. The planned expansion added a second freestanding 20,000 sq. ft. building to the existing campus. The new $3.5 million facility houses SpectraCell's state-of-the-art clinical laboratory operations while the existing building maintains corporate, financial, marketing and administrative functions. The expansion was completed in October of this year.

"Our business has grown at a strong pace over the past few years, as physicians are accepting what research has been demonstrating for a long time - that nutritional deficiencies directly impact health and wellness," says William "Chip" Stanberry, SpectraCell's Chairman and CEO. "As more clients incorporate our specialized laboratory tests into their practices, their patient outcomes improve measurably. As a result, the number of tests performed by us each month has skyrocketed. We outgrew our current building in three years."

SpectraCell is a privately-owned enterprise founded in 1993 by William B. ("Chip") Stanberry, who serves as its Chairman and Chief Executive Officer. The company's number of employees has more than doubled since 2005 and SpectraCell now serves over 3,000 physician clients in 38 states. The new SpectraCell building is located at the Oak Park development in the Westchase Business District in southwest Houston.

About SpectraCell Laboratories - SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced clinical testing with the patented FIA(TM) (Functional Intracellular Analysis) and LPP(TM) (Lipoprotein Particle Profile) tests.

SpectraCell's FIA(TM) testing is an innovative assessment of a patient's nutritional status. Unlike traditional serum, hair and urine tests, SpectraCell's FIA(TM) evaluates how an individual's white blood cells respond to varied environments of over 30 vitamins, minerals, amino acids and antioxidants. As a result, individual differences in metabolism, age, genetics, health, prescription drug usage, absorption rate and other factors are taken into consideration in determining deficiencies that need to be corrected.

SpectraCell's LPP(TM) tests are the most advanced lipoprotein tests available. Unlike traditional cholesterol tests, SpectraCell's LPP(TM) directly measures the number of several classes of lipoprotein particles providing an accurate assessment of cardiovascular risk.


'/>"/>
SOURCE SpectraCell Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
2. SpectraCell Laboratories Offers Additional Test for Heart Attack and Stroke Risk
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
5. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
7. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
8. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
9. Mesa Laboratories Names New Vice President of Sales and Marketing
10. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
11. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
Breaking Medicine Technology: